Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for Prevention of Post-Operative Delirium
NCT02903901Phase 4
Key facts
- Status
- Withdrawn
- Start
- Jun 2015
- Primary completion
- Jun 2018
- Countries
- 1
- Sponsor
- Loyola University Chicago
- Modality
- Small Molecules
- Drugs
- melatonin
- Conditions
- postoperative delirium (POD)
01
Overview
Phase 4, randomised, double-blind trial of melatonin in postoperative delirium (POD), sponsored by Loyola University Chicago. Primary endpoint: Delirium assessment at 1 week. Planned start Jun 2015; status: withdrawn.
02
Design
- Study design
- RandomizedDouble-blind
03
Endpoints
Primary
Delirium assessment
Secondary
Hospital stay
Beyond the preview
Go deeper on NCT02903901.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02903901.